Sign in
CompletedNo phase

MAnual Lymphatic DrAinage to iMprove the outcomE of Patients After Septic Shock

Key facts

Who runs it
University Hospital Ostrava
Where
Czechia1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
24 people enrolled
Started
1 Jun 2023
Ended
28 Nov 2025
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Manual Lymphatic Drainage
  • Usual Care
Record updated
12 December 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • diagnosis of septic shock at admission to ICU
  • sepsis or suspicion of sepsis
  • noradrenaline support required in order to maintain mean arterial pressure ≥ 65 mmHg
  • serum lactate ≥ 2 mmol/L

Who cannot take part

  • patients with septic shock transferred from another department/hospital, if the length of stay at the previous workplace exceeded 72 hours
  • patients with a history of heart failure with NYHA (New York Heart Association) classification ≥ III
  • patients with a history of thromboembolic events
  • patients with uncontrolled infection
  • patients <18 years of age
  • pregnant women with septic shock, in whom the pregnancy has been preserved
  • patients with septic shock and an inauspicious prognosis, or in the phase of withdrawal of treatment
  • patients with septic shock who lack informed consent
  • patients with septic shock, in whom the SOFA score decreased by more than 50% during the day following the withdrawal of noradrenaline (i.e. a subgroup of patients with a rapid improvement of the clinical course after the resolution of septic shock)

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Antimicrobial and supportive therapeutic interventions in patients with septic shock are usually effective - procalcitonin and interleukin-6 levels fall rapidly in most cases, and noradrenaline support can be discontinued within a few days. Unfortunately, only in a small portion of patients, do the organ functions improve at the same time, and in most of them, multi-organ failure persists. Therefore, it is likely that, in addition to infection and the response to infection, other mechanisms are also involved in the persistence of organ failure in patients after septic shock.

The 2 groups in the trial

  • Manual Lymphatic DrainageTreatment being tested

    In addition to usual care, daily manual lymphatic drainage will be performed for five consecutive days. After this period.

  • Usual CareExisting treatment, for comparison

    Usual care for patients with septic shock will be provided.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
MAnual Lymphatic DrAinage to iMprove the outcomE of Patients After Septic Shock: A Safety and Feasibility Pilot Randomized Controlled Trial
Record updated
12 December 2025